Annual CFI
$0.00
$0.000.00%
31 December 2023
Summary:
Y-mAbs Therapeutics annual cash flow from investing activities is currently $0.00, unchanged on 31 December 2023. During the last 3 years, it has risen by +$2.79 million (+100.00%). YMAB annual CFI is now -100.00% below its all-time high of $61.04 million, reached on 31 December 2021.YMAB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.YMAB quarterly CFI is now -100.00% below its all-time high of $61.61 million, reached on 31 March 2021.YMAB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Y-mAbs Therapeutics TTM cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.YMAB TTM CFI is now -100.00% below its all-time high of $61.45 million, reached on 30 September 2021.YMAB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | 0.0% | 0.0% | 0.0% |
| 3 y3 years | +100.0% | +100.0% | -100.0% |
| 5 y5 years | +100.0% | +100.0% | +100.0% |
YMAB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | +100.0% | +100.0% | -100.0% | +100.0% | |
| 5 y | 5 years | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Y-mAbs Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2023 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| June 2022 | - | $0.00(0.0%) | -$526.00 K(-7.2%) |
| Mar 2022 | - | $0.00(-100.0%) | -$567.00 K(-100.9%) |
| Dec 2021 | $61.04 M(-2291.8%) | -$455.00 K(+540.8%) | $61.04 M(-0.7%) |
| Sept 2021 | - | -$71.00 K(+73.2%) | $61.45 M(+4.5%) |
| June 2021 | - | -$41.00 K(-100.1%) | $58.81 M(-0.1%) |
| Mar 2021 | - | $61.61 M(<-9900.0%) | $58.85 M(-2213.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$2.79 M(+41.7%) | -$44.00 K(-98.4%) | -$2.79 M(-28.4%) |
| Sept 2020 | - | -$2.71 M(>+9900.0%) | -$3.89 M(+117.0%) |
| June 2020 | - | -$2000.00(-92.3%) | -$1.79 M(-3.9%) |
| Mar 2020 | - | -$26.00 K(-97.7%) | -$1.86 M(-5.1%) |
| Dec 2019 | -$1.97 M(+739.7%) | -$1.15 M(+85.9%) | -$1.97 M(+124.6%) |
| Sept 2019 | - | -$617.00 K(+722.7%) | -$875.00 K(+181.4%) |
| June 2019 | - | -$75.00 K(-40.5%) | -$311.00 K(-13.6%) |
| Mar 2019 | - | -$126.00 K(+121.1%) | -$360.00 K(+53.8%) |
| Dec 2018 | -$234.00 K(<-9900.0%) | -$57.00 K(+7.5%) | -$234.00 K(+32.2%) |
| Sept 2018 | - | -$53.00 K(-57.3%) | -$177.00 K(+42.7%) |
| June 2018 | - | -$124.00 K(<-9900.0%) | -$124.00 K(<-9900.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $0.00(0.0%) | - | - |
| Dec 2016 | $0.00 | - | - |
FAQ
- What is Y-mAbs Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual CFI year-on-year change?
- What is Y-mAbs Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly CFI year-on-year change?
- What is Y-mAbs Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics TTM CFI year-on-year change?
What is Y-mAbs Therapeutics annual cash flow from investing activities?
The current annual CFI of YMAB is $0.00
What is the all time high annual CFI for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual cash flow from investing activities is $61.04 M
What is Y-mAbs Therapeutics annual CFI year-on-year change?
Over the past year, YMAB annual cash flow from investing activities has changed by $0.00 (0.00%)
What is Y-mAbs Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of YMAB is $0.00
What is the all time high quarterly CFI for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly cash flow from investing activities is $61.61 M
What is Y-mAbs Therapeutics quarterly CFI year-on-year change?
Over the past year, YMAB quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Y-mAbs Therapeutics TTM cash flow from investing activities?
The current TTM CFI of YMAB is $0.00
What is the all time high TTM CFI for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high TTM cash flow from investing activities is $61.45 M
What is Y-mAbs Therapeutics TTM CFI year-on-year change?
Over the past year, YMAB TTM cash flow from investing activities has changed by $0.00 (0.00%)